Anti-ZFP90 monoclonal antibody

Pre-made anti-ZFP90 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to ZFP90/ZFP90 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2818-Ab-1/ GM-Tg-hg-IP2818-Ab-2Anti-Human ZFP90 monoclonal antibodyHuman
GM-Tg-rg-IP2818-Ab-1/ GM-Tg-rg-IP2818-Ab-2Anti-Rat ZFP90 monoclonal antibodyRat
GM-Tg-mg-IP2818-Ab-1/ GM-Tg-mg-IP2818-Ab-2Anti-Mouse ZFP90 monoclonal antibodyMouse
GM-Tg-cynog-IP2818-Ab-1/ GM-Tg-cynog-IP2818-Ab-2Anti-Cynomolgus/ Rhesus macaque ZFP90 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2818-Ab-1/ GM-Tg-felg-IP2818-Ab-2Anti-Feline ZFP90 monoclonal antibodyFeline
GM-Tg-cang-IP2818-Ab-1/ GM-Tg-cang-IP2818-Ab-2Anti-Canine ZFP90 monoclonal antibodyCanine
GM-Tg-bovg-IP2818-Ab-1/ GM-Tg-bovg-IP2818-Ab-2Anti-Bovine ZFP90 monoclonal antibodyBovine
GM-Tg-equg-IP2818-Ab-1/ GM-Tg-equg-IP2818-Ab-2Anti-Equine ZFP90 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2818-Ab-1/ GM-Tg-hg-IP2818-Ab-2; GM-Tg-rg-IP2818-Ab-1/ GM-Tg-rg-IP2818-Ab-2;
GM-Tg-mg-IP2818-Ab-1/ GM-Tg-mg-IP2818-Ab-2; GM-Tg-cynog-IP2818-Ab-1/ GM-Tg-cynog-IP2818-Ab-2;
GM-Tg-felg-IP2818-Ab-1/ GM-Tg-felg-IP2818-Ab-2; GM-Tg-cang-IP2818-Ab-1/ GM-Tg-cang-IP2818-Ab-2;
GM-Tg-bovg-IP2818-Ab-1/ GM-Tg-bovg-IP2818-Ab-2; GM-Tg-equg-IP2818-Ab-1/ GM-Tg-equg-IP2818-Ab-2
Products NameAnti-ZFP90 monoclonal antibody
Formatmab
Target NameZFP90
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-ZFP90 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2818-Ag-1Recombinant multi-species ZFP90/ FIK/ NK10 protein


    Target information

    Target IDGM-IP2818
    Target NameZFP90
    Gene ID146198,22751,498945,704279,100683215,101094642,100139934,100066734
    Gene Symbol and Synonyms6430515L01Rik,FIK,KRAB17,mKIAA1954,NK10,zfp-90,Zfp64,Zfp83,ZFP90,ZNF756
    Uniprot AccessionQ8TF47,Q4V8A8
    Uniprot Entry NameZFP90_HUMAN,ZFP90_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000184939
    Target ClassificationN/A

    The target: ZFP90, gene name: ZFP90, also named as FIK, NK10, ZNF756, zfp-90. This gene encodes a member of the zinc finger protein family that modulates gene expression. The encoded protein derepresses the transcription of certain fetal cardiac genes and may contribute to the genetic reprogramming that occurs during the development of heart failure. Genome wide association studies have identified this gene among ulcerative colitis risk loci. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Mar 2015].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.